What Happened: The FTC is disputing “junk patent listings” for diabetes, weight loss, asthma and COPD drugs. This initiative ...
In an attempt to curb inaccurate patent listings in the Food and ... for medicines they rely on,” FTC Chairwoman Lina Khan ...
The US Federal Trade Commission (FTC) has expanded its campaign against so-called ‘junk’ patents intended ... disputing more than 300 patent listings in its Orange Book covering 20 brands ...
In a warning letter sent to several drugmakers, including Ozempic's Denmark-based manufacturer Novo Nordisk, the FTC announced that it plans to challenge so-called "junk patents" that keep the ...
Care.com Reaches $8.5 Million US FTC Settlement Over Job Listings, Renewals By Jonathan Stempel (Reuters) -Care.com, a platform for providing in-home care services to children, older adults and ...
[21] Three of the comments highlight the FTC’s ongoing efforts to dispute “improper” Orange Book patent listings that the agency argues can harm drug competition and constitute a violation ...
The bill has been passed as the FTC has launched a crackdown on what it calls ‘junk patents’, sending warning letters to 10 manufacturers disputing more than 300 patent listings covering 20 ...
Care.com did not admit or deny wrongdoing in agreeing to settle. The FTC said Care.com enticed customers to buy auto-renewing memberships by overstating the number of jobs, or "gigs," on its ...
Care.com did not admit or deny wrongdoing in agreeing to settle. The FTC said Care.com enticed customers to buy auto-renewing memberships by overstating the number of jobs, or “gigs,” on its ...